One of the great things about trade shows and conferences is connecting with educators and find out how they are using chromatography in the classroom.
At the NAOSMM conference we were thrilled to talk with Paul Weller, Science Laboratory Manager at Elon University’s Department of Chemistry.
In this video, Weller explains how he uses Thin Layer Chromatography in the classroom.
The Annual Conference of the National Association of Scientific Materials Managers (NAOSMM) is one of the more unique shows we get to attend.
In this video, Heather McCollor of the Macalester College Chemistry Department explains what makes the gathering special for her and her colleagues:
It’s always great to hear from satisfied customers – at the NAOSMM show in Norfolk, Virginia, we heard from Todd Wincek of the Chemistry Department of Middle Tennessee State University, who told us about why he likes to work with us:
The National Association of Scientific Materials Managers 37th Annual Conference is underway in Norfolk, Virginia.
Here’s a quick look at Day 1 from Booth 51:
Last week’s post about our company’s LEAN Journey has led to a great new connection, namely Karen Wilhelm.
Karen did an excellent job chronicling her discovery of this blog, our connection, and her plans to visit us in the fall – click here to read the full account.
We’re just days away from the 2010 NAOSMM Conference in Norfolk, Virginia.
Last year’s conference in Idaho was phenomenal – we made several new friends and strengthened numerous bonds.
If you are coming to this year’s NAOSMM conference in Norfolk, please come by BOOTH 51 to say “Hi” and let us know if there’s anything we can do to help in your chromatography needs.
If you are not able to join us in Virginia, please check back here for updates and/or follow us on Twitter.
Our Company started working with the Delaware 
Manufacturing Extension Partnership (DEMEP) in January of 2009 to see where we could streamline procedures, operate more efficiently, and make ongoing improvements.
Anyone who has embarked on a Lean Journey knows that it is an ongoing process with new tools and concepts to consider on a regular basis.
Thanks to this partnership, we’ve been able to produce our quality Thin Layer Chromatography plates more efficiently, improve our ordering system, and move to a four-day work week.
This week, our partners at DEMEP are working with us to explore more ways to make improvements to our system.
We just thought this might be a good opportunity to take a trip back in the time machine that is video to show some highlights of our first session with DEMEP:
Chemical and Engineering News has a report about a new Chemical Research in Toxicology paper that outlines how 
Thin Layer Chromatography is used to differentiate between a potent carcinogen found in diesel exhaust (3-nitrobenzanthrone or 3-NBA) and 2-NBA, which is largely the product of a nitration reaction that happens spontaneously in the atmosphere.
Here’s an excerpt:
The team incubated each isomer with DNA and a variety of enzymes, and then used thin layer chromatography to determine the extent to which the DNA had been altered. Because 2-NBA did not form potentially harmful DNA adducts, the researchers determined that it is not a substrate for enzymes that activate 3-NBA toward DNA. In experiments with intact human liver cells, 3-NBA again generated DNA adducts, whereas 2-NBA did not.
More than 100 leaders in the Bio, Pharma, and Health 
Industries gathered at Delaware Technical and Community College in Wilmington, Delaware on Friday, June 25 to hear from Governor Jack Markell, Former U.S. House Majority Leader Richard Gephardt, and Rich Fante, President of AstraZeneca US and Regional VP North America, as they announced the findings of a report from the 
Council for 
American Medical Innovation about the future of Medical Innovation.
Click Here to download a copy of the full report.
Here’s some excerpts from Media Coverage of the event:
The United States must invest more aggressively and stress development of more scientists if it is to retain its position as the worldwide leader in medical innovation, with the burden falling on government and community leaders to foster growth, former U.S. House Majority Leader Richard Gephardt said Friday.
…
“It is critical to our national and economic interests that we own medical innovation in the future as much as we owned mechanical innovation in the past,” Markell said. “Big and serious companies are moving medical companies overseas. … We want these companies to stay here and grow here.”
…
Released at the conference was a 62-page report that focused on problems in the current U.S.
medical technology system and suggested improvements. The report was essentially a compendium of interviews with 72 experts in the biomedical and capital investment industry, as well as advocacy groups leaders.
Four major themes from the report emerged:
•More public/private partnerships are need to bring research to market.
•Government needs to provide better research and development tax credits and adopt favorable tax policies to keep manufacturing jobs stateside.
•The U.S. Food and Drug Administration regulatory process must be overhauled so new drugs and devices can be evaluated sooner.
•The bioscience curriculum in public schools must be significantly enhanced.
Click Here to read the article from the News Journal.
At the event, CAMI and We Work for Health unveiled a public policy agenda based on the recent Battelle study, “Gone Tomorrow? A Call to Promote Medical Innovation, Create Jobs, and Find Cures in America.” The study, commissioned by CAMI, reflects direct feedback of leaders representing patients, academia, private industry, research, labor, venture capital, government, and economic development.
Medical innovation generates high-quality jobs, and if properly fostered, could generate many more across the state. Despite tough economic times, the biomedical industry grew 14.4 percent in the last jobs cycle, compared to 4.3 percent for all other industries. In Delaware, biopharmaceutical and related fields directly employ 11,500 workers in 247 companies according to a report published in July 2009 by the Center for Applied Demography and Survey Research at University of Delaware. Medical innovation holds the promise of finding more cures for more diseases at a faster rate and Delaware companies are leading the way in this important research and development.
Click Here to read the full article from the Business Ledger.
Despite tough economic times the Biomedical industry grew over 14-percent in the last jobs cycle. No state has been better at this than Delaware. Bio-pharmaceutical and related fields alone have directly employed nearly 12,000 workers in 247 companies.
Click Here for the full report from WILM NewsRadio
The following are videos from the various speakers at the event:
A recent article from the Wilmington News Journal features the work of Analtech’s Micky Jones – designer of the “Scientist” Poken.
Here’s some excerpts:
Pokens, which come in a variety of character designs with outstretched palms, exchange an encrypted code when the palms touch. The platform plugs into your computer’s USB port to upload contact information including e-mails, photos, phone numbers and social-networking accounts.
Micky Jones, 25, expects the Poken to take off in this country as it has elsewhere. In March, he became the distributor for PokenPhilly.com, operating in an area that includes Delaware, Philadelphia, Baltimore and New York. A basic Poken costs $19.95, with no additional fees, he said. Information is updated to all contacts as changes such as new phone numbers or job addresses are made on the Poken account online.
“If a client moves, you’re going to be able to still get in touch with them because the information will change on your account. It’s just like Facebook,” said Jones, who works full time as creative director for Analtech Inc., a Newark company that specializes in chromatography, the separation of mixtures.
To read the complete article, click here.
To find out more about the Scientist Poken, click here.
